Acadia Pharmaceuticals | ACAD - Ebitda

Precio De Mercado
22.44
Cambio Diario
0.24 1.08%
Mensual
0.81%
Anual
54.02%
Q2 Expectativa
21.49




Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
ALKERMES USD 100.31M 21.24M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Incyte USD 414.5M 92.42M 2025-12
J&J USD 7.19B 2.32B 2025-12
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pfizer USD 6.08B 351M 2025-09
Prothena USD -39.53M 12.25M 2025-09
PTC Therapeutics USD -70.99M 91.62M 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09